RSS   Newsletter   Contact   Advertise with us
Post Online Media

Recro Pharma appoints Michael Celano as CFO

Recro PharmaRecro Pharma, a specialty pharmaceutical company, announced the appointment of Michael Celano as chief financial officer.

Mr. Celano brings to Recro more than 35 years of financial leadership experience in the life sciences and biopharmaceutical industries. He has served as CFO at Kensey Nash and BioRexis. He is also on the board of Orasure Technologies.

READ MORE Recro Pharma appoints Karen A. Flynn to its board

Mr. Celano has also served as CFO of Makindus and at Drugscan. Prior to entering the biopharmaceutical industry, he was a Partner at Arthur Andersen/KPMG, where he worked from 1980 until 2004, and led its life sciences practices.

He received a bachelor’s degree in accounting from St. Joseph’s University.

 LATEST MOVES FROM Pennsylvania 

More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy